Satellite Symposium AstraZeneca 11:00-13:00. Satellite Symposium Celgene International 14:00-16:00

Transcription

1 Hall 7.1 RAI Auditorium Elicium 2 Hall 7.2 Elicium 1 Forum Hall 3.1 Hall 3.2 Room G102 Room G104 Room G106 Hall 5.1 Room E102 Room D201 Room D203 Room E104 Sanofi Boehringer Ingelheim Sanofi AstraZeneca prime Genomic Health Novartis 13:00-16:00 Roche 14:00-19:00 Celgene International Teva Pharmaceuticals Europe BV Pfizer MSD EONS Workshop Breakthrough Pain Nurses 13:00-17:30 Lilly Novartis Celgene International Boehringer Ingelheim prime Bayer Health Pharmaceuticals, ESMO GA BIG : INTEGRATE: The Potential of Data Sharing 16:45-18:45 Opening Ceremony 19:15-21:00 Networking Reception 21:00-22:00

2 Hall 7.1 RAI Auditorium Elicium 2 Hall 7.2 Elicium 1 Forum Hall 3.1 Hall 3.2 Room G102 Room G104 Hall 5.1 Room G106 Room E102 Room D201 Room D203 Room E104 Room E107 #ECC2013 #ECCAudit #ECCE2 #ECCH7 #ECC2013 #ECC2013 #ECC2013 #ECCH3 #ECC2013 #ECC2013 #ECCH5 #ECC2013 #ECC2013 #ECC2013 #ECC2013 #ECC2013 #ECC2013 T.L. T.L. T.L. T.L. T.L. T.L. Special Lecture T.L. Panel of Experts Breast Colorectal Lung GU-Prostate Head & Neck Surgical Haem. Breast Surgical v v v Bone Metastasis: Causes, Consequences and Role of Aggressive Surgery for Peritoneal Metastases Novel Therapy Options in Early Stage NSCLC Bone Targeted Prostate Current Role of HPV in Head and Neck Successful Clinical Translation of Preclinical Combinations of and Immunotherapy Limitation and Indication of Minimally Invasive Surgery for Gastric Novel Targets in Diffuse Large B-cell Tumour Board - Breast T.L. Oncoplastic Surgery - Standard of care Opening Biological Basis of Therapy Opening Nursing v 9:30-11:00 Nursing Opening and Award P.P. P.P. P.P. P.P. P.P. S.S. S.S. P.P. Society P.P. AES P.P. S.S. S.S. S.S. Breast Colorectal Lung GU-Prostate Melanoma Nursing Head & Neck Surgical Haem. Patients Nursing Basic science OncoTech Paediatric v v v Ù v v 11:15-13:40 Breast - Advanced Disease I 13:45-15:55 11:15-14:10 Colorectal I 11:15-14:00 Lung - Localised and 11:15-14:05 Prostate 11:15-13:25 Melanoma and Skin The Impact of - Exploring Complexity and Special Needs in Specific s Induction Chemotherapy in the of Squamous Cell Radiobiology/ / Physics/ Techniques Society of Surgical (ESSO) 11:15-13:40 Haematological This Week on Talking About With Richard Sullivan: A Mock TV Talk Show Advanced Nursing Roles Targeting the Microenvironment Advances in Preclinical Research Spec.S. Spec.S. Spec.S. Spec.S. Spec.S. Spec.S. Spec.S. AES Spec.S. Spec.S. Inter.AcT,WSP GU-Prostate Regulatory Nursing Head & Neck Surgical Haem. Patients Basic science General General v v v Ù Approach to Castration- Dilemma of Crossover in Clinical Trial Design of Agents of Obvious Activity Young People Facing The Role of Biological Imaging in the Assessment in Immune System Interactions Minimal Invasive Surgery: What s the Benefit? of Chronic Lymphocytic Leukaemia Adherence to : Is it Worth it? Genetics and Epigenetics for Biomarker for Response Joint ECCO/BDA Special - Accelerating Patient Access to Innovative Drugs in Europe? Eurocan Platform in Teenagers and Young Adults Young Oncol. p E.S. E.S. S.S. S.S. S.S. S.S. P.P. S.S. Society S.S. AES P.P. S.S. S.S. Breast Colorectal Lung GU-Prostate Melanoma Nursing Head & Neck General Haem. Patients Nursing Epidemiology Imaging v v Ù v Ì in Early Breast Optimal Approaches for Localised Rectal Implications for New Targets in Lung Castration Targeting Cells, Microenvironment and Stem Cells New Classification of Melanoma and its Consequences for Pain Barriers: Can we Overcome Them? 15:30-18:10 Novel Targets Organisation for Research and of (EORTC) - Clinical Research: What are we up to in 2013? Dissecting Total Therapy for Multiple Myeloma : now What? Returning to Normal Life Impact of on Patients and Families Screening- Redefining the Modality of Screening Imaging to Support Drug Astellas Pharma Europe Ltd Bristol-Myers Squibb GlaxoSmithKline prime Bayer Health Pharmaceuticals, Pierre Fabre Medicament ESMO Women for 18:15-20:00 T.L.=Teaching Lecture, S.S.=Scientific, E.S.=Educational, Spec.S.=Special, DEB=Debate, Inter.AcT,WSP = Interactive Workshop, Case Presentation=Interactive with Case Presentation, AES=Advocacy/Ethics s, OPF=Oncopolicy Forum s, P.P.=Proffered Papers, P.D.=Poster Discussion

3 Hall 7.1 RAI Auditorium Elicium 2 Hall 7.2 Elicium 1 Forum Hall 3.1 Hall 3.2 Room G102 Room G104 Hall 5.1 Room G106 Room E102 Room D201 Room D203 Room E104 Room E107 #ECC2013 #ECCAudit #ECCE2 #ECCH7 #ECC2013 #ECC2013 #ECC2013 #ECCH3 #ECC2013 #ECC2013 #ECCH5 #ECC2013 #ECC2013 #ECC2013 #ECC2013 #ECC2013 #ECC2013 Highlights T.L. T.L. T.L. T.L. T.L. T.L. T.L. T.L. T.L. T.L. Special Lecture T.L. Breast Colorectal GU-other Melanoma Nursing Head & Neck Surgical Drug Devel. Basic science Paediatric Young Oncol. v v v v v p State of the art in Neoadjuvant Therapy of Breast for Rectal Short vs Long Course - When and how? At What Price do we Treat Patients with Testicular? Melanoma: New Paradigms of and New Toxicities Collaborative International Nursing Research is Improving but Still has a Long way to go From Novel Insights in B to Targeted Approaches in EGFR Targeting and its Role for Individualisation Surgical of NET Liver Metastases Pharmacogenetics in the Clinic Genetic Variation and - What Next? Vasculogenesis: A new Target to Improve the of Solid Tumours P.P. P.P. P.P. P.P. P.P. S.S. Society Society S.S. P.P. AES P.P. Society Society Society Society Breast Colorectal Lung GU-other Epidemiology Nursing Breast Haem. Basic science Patients Nursing Imaging Paediatric General Regulatory Ì v v Ù v v 8:45-11:20 Breast - Early Disease Colorectal II 8:50-11:35 Lung - Other 9:00-11:35 Public Health and Epidemiology Palliative in 2014 Society of Breast Specialists (EUSOMA) - Ensuring Quality in Breast Society for Radiology and (ESTRO) of Special s - Challenges in Clinical Routine 9:00-11:35 Basic Science/ Research Best Practices: Advocacy - Didn t we do Well? Anniversary AES P.D. P.D. P.D. Nursing Patients Colorectal Lung GU-other v Ù Keynote Lecture 11:00-12:30 11:30-12:15 Mouse Hospital and the Co-Clinical Trial Project - Colorectal I Lung Other EONS - 30th Anniversary: Collaboration - Reflections on the Past, Thinking Ahead for the Future 11:15-12:00 Panel Discussion: Quality of Life / Palliative - Do Patients Perceive Quality of Life the Same way Their Doctors do? Improvements in Nursing Association of Nuclear Medicine (EANM) - Diagnostic Imaging and Prostate Society for Paediatric (SIOPE) 0 School of (ESO) - The Importance of Skills in Running Services By-passing the Blood Brain Barrier in Paediatric 0 Society of Pharmacy (ESOP) II 12:30-14:45 Spec.S. Spec.S. Spec.S. Spec.S. Spec.S Spec.S. Spec.S. AES DEB Spec.S. Inter.AcT,WSP Spec S. Spec.S Spec S. GU-other Epidemiology Nursing Regulatory Surgical Drug Devel. Patients Basic science Imaging Nursing Young Oncol. Paediatric Young Oncol. Ì v v v Ù v p v p Bladder Aspirin - A Wonder Drug in the Fight Against? Toxicities Related to Chemotherapy and Targeted Therapy Matching p-values to Clinical Needs: Statistical Significance vs Clinical Relevance How Should Complex s Therapy be Monitored to Guarantee Quality? Centralisation of Complex Surgery: Do Outcomes Improve? Epigenetics in Medicine Stem Cells are Responsible for Failure in Tumour Response Assessment How to win Friends and Influence (the right) People! How to be a Happy Oncologist New Insights Into Biology of Brain Tumours Publishing Connect S.S. S.S. S.S. S.S. E.S. S.S. S.S. S.S. Society S.S. AES Society S.S. S.S. Society S.S. Society Breast Breast General GU-other Melanoma Regulatory Surgical Gynaecological Drug Devel. Patients CNS Symptom Science OncoTech Basic science Paediatric General v Ù Ì v 15:00-17:00 Technical and Biological s in Breast Joint ECCO/ ASCO - Improvements and Outcomes in Breast ESMO Clinical Practice Guidelines New Challenges in Renal Cells: What is Worth Pursuing for Melanoma Exploiting Defective DNA Damage Response Pathways in Tumours Outcome Measures in Clinical Trial Design Minimal Pancreatic : Is it a Surgical Disease? Society of Gynaecological (ESGO) Optimal use of Kinase Targeted Inhibitors (TKIs) Some Patients are More Equal Than Others / Satnav : Where do I Find the Best? Association of Neuro- (EANO) End of Life Technologies Association for Research (EACR) - micrornas in DEB DEB Spec.S. DEB Spec.S Spec.S DEB Spec.S. DEB DEB AES DEB DEB Inter.AcT,WSP Round Table Breast Colorectal Lung GU-other Melanoma Nursing Head & Neck Surgical Haem. Drug Devel. Patients Regulatory Imaging Education Young Oncol. v v Ù p p 17:10-18:10 Axillary Dissection Should be Avoided in Patients With Positive Sentinel Nodes Primary Tumour Should be Removed in Synchrous Colorectal Concurrent Chemo- Prediction of Outcome and Toxicity Believes There is no Need for More VGFR TKIS to Treat Renal Cells New Clinical in new Targeted Therapies Hope Across Concurrent Chemoradiation is the Standard of in Larynx-preserving Strategies for Patients With Locally Advanced Laryngeal and Hypopharyngeal Is There a Role for Surgery in HCC? Autologous Stem Cell Transplantation is the First-line for High Risk Diffused Large Cell Progression Free Survival is a Valid Endpoint in Drug Empowering Young People With - a Passport for Survivors Body Surface Area Based Dosing is a Misconception the Actual Value of PET Scanning is Overestimated How to Communicate With High-risk Population(s) How to Improve er for Across Europe of Rhabdomyosarcoma in Children and Adolescents Across the Atlantic: Time for Increasing Joint Initiatives? 14:45-16:45 FLIMS Alumni Club (FAC) Bristol-Myers Squibb Merck Serono Pfizer 18:30-20:00 EONS GA 18:30-20:00 ESTRO GA ESSO GA prime Bayer Healthcare Pharmaceuticals T.L.=Teaching Lecture, S.S.=Scientific, E.S.=Educational, Spec.S.=Special, DEB=Debate, Inter.AcT,WSP = Interactive Workshop, Case Presentation=Interactive with Case Presentation, AES=Advocacy/Ethics s, OPF=Oncopolicy Forum s, P.P.=Proffered Papers, P.D.=Poster Discussion Lilly EACR GA 18:00-19:30 SIOP Europe GA

4 Hall 7.1 RAI Auditorium Elicium 2 Hall 7.2 Elicium 1 Forum Hall 3.1 Hall 3.2 Room G102 Room G104 Room G106 Hall 5.1 Room E102 Room D201 Room D203 Room E104 Room E107 #ECC2013 #ECCAudit #ECCE2 #ECCH7 #ECC2013 #ECC2013 #ECC2013 #ECCH3 #ECC2013 #ECC2013 #ECC2013 #ECCH5 #ECC2013 #ECC2013 #ECC2013 #ECC2013 #ECC2013 Highlights T.L. Case Presentation T.L. Case Presention T.L. T.L. T.L. Panel of Experts T.L. T.L. T.L. T.L. Breast Colorectal Lung GU-Prostate Nursing Gynaecological Lung Elderly CNS Symptom Science v v Ì Ì Best of Locally Advanced Inoperable Breast Patient with Colorectal Liver Metastasis Upfront Palliation Improves Survival in NSCLC Patient with Localised Prostate Nurse Navigation is a Good Help for Patients but With Some Restrictions How to Integrate Sentinel Nodes in Therapy? Invasion and Resistance Tumour Board - Lung The Best for Older Patients With Breast The Way to Improve Outcome in Newly-Diagnosed Glioblastoma Nutrional status in Relation to Modalities Next Generation S.S. S.S. S.S. S.S. S.S. S.S. S.S. S.S. S.S. P.P. P.P. P.P. P.P. OPF Inter.AcT,WSP S.S. Breast Colorectal Lung General Gynaecological Nursing Noncolorectal Diagnostic Drug Devel. Elderly CNS Nursing Oncopolicy Forum OncoTech Paediatric v Ì v Ù v Breast : From Biology to Strategies in Colorectal Planning of Lung Using Innovative Therapy Joint ECCO / JSCO : Extended Lymph Adenectomy in GI Potential Novel Targets in Gynaecological Technology Issues: Healthcare 2.0 Procedures in Liver Metastases: Conventional and Future Immunology from Bench to Bedside How Next Generation is Changing Decision Making 9:00-11:44 Drug 9:00-11:30 in the Older Patient Central Nervous System Supportive and Palliative / Survivorship and Rehabilitation ECCO and Policy: Shaping the Future Through Solid Science and Strategic Partnerships MIRACLE Workshop on Circulating Tumour Cell Detection Empowering Survivors of Childhood and Adolescent P.D. P.D. P.D. P.D. P.D. Colorectal Breast GU-Prostate Noncolorectal Symptom Science Keynote Lecture Ì 11:30-12:15 Improved Cure Through - Basis and Perspectives - Colorectal II Breast Prostate Noncolorectal Symptom Science 9:00-16:45 FLIMS Alumni Club (FAC) Workshop III 12:30-14:50 Spec.S. Spec.S Spec.S Spec.S Spec.S. Spec.S. Spec.S. Spec.S. Spec.S. OPF Spec.S. Gynaecological Nursing Noncolorectal Sarcoma Symptom Science Young Oncol. Nursing Oncopolicy Forum Paediatric v v Ì p v Ù v Improving Therapy for Locally Advanced Cervical Survivorship and Follow up Controversies in Gallbladder MRI and Prostate : Optimisation of Targeting and Delivery Medical of GIST The Mouse Hospital in Drug Symptom via Internet Improving Handson Education for EONS - ESO Joint - Surgery and Nursing Horizon 2020: EU Funding for You and Your Team Shared Challenges of Small Group Trials S.S. E.S. Society E.S. S.S. S.S. S.S. S.S. S.S. S.S. E.S. S.S. S.S. OPF S.S. S.S. Colorectal Lung General GU-other Melanoma Nursing Sarcoma Regulatory Symptom Science Young Oncol. Epidemiology Oncopolicy Forum OncoTech Paediatric v v Ì p Ì Ù v 15:00-17:00 Classification of CRC: Ready for Prime Time? for Upfront Resectable NSCLC Society for Medical (ESMO) for Renal Do Resistance Mechanisms Require Combination in Immunomodulated and Targeted Therapies? The Elderly Patient Interrogating Minimal Residual Disease: What is new? Evidence-based : The Large Database Perspective Innovative Modalities in Sarcoma Pharmaceutics Mood Disorders in Patients Integrating Genetic Information Into Daily Practice Lifestyle, Exercise and Vitamins Medicine: Spotlight on Pioneering National Programmes Chip Technologies Targeted Drugs and Medicine in Paediatric DEB Spec.S. DEB DEB Spec.S. DEB Special Lecture DEB DEB Spec.S. Spec.S. DEB Inter.AcT,WSP Spec.S. Diagnostic Colorectal Lung GU-Prostate Melanoma Nursing Drug Devel. Sarcoma Basic science CNS Regulatory Education General Young Oncol. v v p p 17:10-18:10 the Assessment of Biomarkers on Single Biopsy of Primary Tumour is Sufficient to Determine Systemic Therapy in Disease Risk and Benefits of Organ Preservation in the of Rectal Believes in 5 years the Majority of Non-Small Cell Lung s Will be Treated With Targeted Therapies Pfizer low Risk Prostate Should not be Treated as New for Complex Basal Cell Carcinoma prime the Term Medicine is too Narrow, and Should be Renamed and 17:00-17:45 Can Drug Approval Keep Pace With Research in? Merck Serono new Technologies in RT do not Require Randomised Clinical Trials Metastasis of Sarcoma Should be Removed if Complete Response is Achievable Imaging Society for Current and Future Approaches for Recurrent Glioblastoma GlaxoSmithKline the EU Clinical Trials Directive has Harmed Clinical Studies Dealing With Angry Patients and Families as a Provider 17:00-18:30 Quality in in Europe - EURECCA T.L.=Teaching Lecture, S.S.=Scientific, E.S.=Educational, Spec.S.=Special, DEB=Debate, Inter.AcT,WSP = Interactive Workshop, Case Presentation=Interactive with Case Presentation, AES=Advocacy/Ethics s, OPF=Oncopolicy Forum s, P.P.=Proffered Papers, P.D.=Poster Discussion

5 Hall 7.1 RAI Auditorium Elicium 2 Hall 7.2 Elicium 1 Forum Hall 3.1 Hall 3.2 Room G102 Room G104 Room G106 Room E102 Room D201 Room D203 Room E104 Room E107 #ECC2013 #ECCAudit #ECCE2 #ECCH7 #ECC2013 #ECC2013 #ECC2013 #ECCH3 #ECC2013 #ECC2013 #ECC2013 #ECC2013 #ECC2013 #ECC2013 #ECC2013 #ECC2013 Highlights T.L. T.L. T.L. T.L. T.L. T.L. T.L. T.L. T.L. T.L. OPF T.L. Inter.AcT,WSP Lung Breast Gynaecological GU-other Basic science Noncolorectal Sarcoma Nursing Symptom Science Oncopolicy Forum Paediatric Nursing v v Ì Ù v v Practical Tips and Tricks With Recently Approved Targeted Agents in NSCLC International Consensus Guidelines for Advanced Breast : An Update Incorporating Anti-vascular Ovarian Modern Penile Metastase Current and Future Strategies in the of Operable Oesophageal Procedures in Liver Metastases: Conventional and Future Measures Role of Expert Centres in the Sarcomas Together we re Better: Establishing a Community Nursing Programme to Improve Through Shared Working Mechanisms of - Related Symptoms in Patients Reference Networks: Facilitating for Rare Patients? Tailored Therapy of Childhood Leukaemia S.S. E.S. Society P.P. P.P. S.S. P.P. S.S. P.P. S.S. S.S. S.S. OPF S.S. S.S. S.S. General Lung GU-other Gynaecological Nursing Basic science Noncolorectal Sarcoma Nursing Elderly Symptom Science Oncopolicy Forum CNS Paediatric OncoTech Breast and Prostate s What can we Learn From Each Other? v v v Ì Ì Ù v Lung in Non-smokers Association of Urology (EAU) 8:45-11:25 Gynaecological Symptom Metabolism and Noncolorectal Innovative Imaging Strategies for Individualisation Sarcoma: Soft Tissue and Bone How to put Evidence Into Daily Nursing Practice Geriatric Assessment and Their Clinical Applications Diagnosis and of Oncological Emergencies Evidence and Policy: Towards Optimal Prioritisation of Scarce Resources in Profiling in Neuro- Spec.S. Spec.S. Spec.S. DEB Spec.S. DEB Spec.S. Spec.S. Spec.S. Spec.S. OPF DEB DEB Spec.S. Breast Lung GU-Prostate Gynaecological Basic science Noncolorectal Sarcoma Nursing Elderly Oncopolicy Forum CNS Paediatric OncoTech v v Ì Ù v Personalising Adjuvant in Early Breast The Pathology of Lung and its Clinical Implications Castration : New Therapies Supra-radical Surgery is not the Standard of for Advanced Ovarian Autophagy in and Therapy Chemoradiotherapy Compensates for Poor Surgery in Gastric Stem Cell Therapy for Prevention of Salivary Gland Toxicity Retroperitoneal Sarcomas Advanced Practitioners Roles in : Where Next? Outcome Issues for the Older Patient Oncopolicy 2020: Taking Things to the Next Level Plays no Role in the of Primary CNS The Future of Paediatric in Europe Children With Sarcoma and Their Families Should be Screened for Family Syndrome Mutations T.L.=Teaching Lecture, S.S.=Scientific, E.S.=Educational, Spec.S.=Special, DEB=Debate, Inter.AcT,WSP = Interactive Workshop, Case Presentation=Interactive with Case Presentation, AES=Advocacy/Ethics s, OPF=Oncopolicy Forum s, P.P.=Proffered Papers, P.D.=Poster Discussion Facing a Future of Long Term Conditions: Challenges for Nurses Enhancing Conventional Oncological s With New Technologies Repainting and Tracking in Ion Beam Therapy